Influence of vitamin D3 metabolites on cell proliferation and cytotoxicity of adriamycin in human normal and neoplastic cells

Toxicology in Vitro

Volumn 16, Issue 6, 2002, Pages 663-667

  Gruber, B M ^a   Anuszewska, E L ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; DOXORUBICIN; ANTINEOPLASTIC AGENT;

ARTICLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG RESISTANCE; FIBROBLAST; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; MELANOMA CELL; TUMOR CELL; TUMOR GROWTH; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG INTERACTION; LD 50; MELANOMA; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CALCIFEDIOL; CALCITRIOL; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG INTERACTIONS; DRUG RESISTANCE, NEOPLASM; FIBROBLASTS; HUMANS; LETHAL DOSE 50; MELANOMA; TUMOR CELLS, CULTURED;

EID: 0036890116     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(02)00094-2     Document Type: Article

References (27)

1. Anuszewska E.L., Gruber B. DNA damage and repair in normal and neoplastic cells treated with adriamycin. Acta Biochimica Polonica. 41(4):1994;385-390.
2. Anuszewska E.L., Gruber B.M., Koziorowska J.H. Studies on adaptation to adriamycin in cells pretreated with hydrogen peroxide. Biochemical Pharmacology. 54:1997;597-603.
3. Brenner R.V., Shabahang M., Schumaker L.M., Nauta R.J., Uskokovic M.R., Evans S.R.T., Buras R.R. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells. Cancer Letters. 93:1995;77-82.
4. Colston K.W., Chander S.K., Mackay A.G., Coombes R.Ch. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochemical Pharmacology. 44(4):1992;693-702.
5. Delissalde F., Hernandez M.A., Barron A., Bermejo L., Arias J., Halhali A., Castro I. Vitamin D induces proliferation in rat endometrium cultured cells. Revista de Investigacion Clinica. 50(2):1998;113-118.
6. Doroshow J.H. Anthracyclines and anthracenediones. Chabner B.A., Longo D.L. Cancer Chemotherapy and Biotherapy. 1996;409 Lippincott-Raven Publishers, Philadelphia.
7. 3 on proliferation of cancer cells in vitro. Cancer Letters. 120:1997;65-69.
8. 3. Breast Cancer Research Treatment. 55(1):1999;29-39.
9. 2 adaptive dose on DNA damage in human neoplastic cells treated with adriamycin. Acta Poloniae Pharmaceutica - Drug Research. 57(3):2000;193-198.
10. Gruber B.M., Anuszewska E.L., Skierski J.S. Activation of programmed cell death (apoptosis) by adriamycin in human neoplastic cells. Mutation Research. 484:2001;87-93.
11. 3 induces elevated expression of the cell cycle-regulating genes p21 and p27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngologica. 121(1):2001;103-109.
12. 3 inhibits tumor growth and metastasis of a murine osteosarcoma model. Anticancer Research. 21(1A):2001;321-324.
13. Hansen Ch.M., Mäenpää P.H. EB1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochemical Pharmacology. 54:1997;1173-1179.
14. Konety B.R., Lavelle J.P., Pirtskalaishvili G., Dhir R., Meyers S.A., Nguyen T.S., Hershberger P., Shurin M.R., Johnson C.S., Trump D.L., Zeidel M.L., Getzenberg R.H. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. Journal of Urology. 165(1):2001;253-258.
15. Koren R., Hadari-Naor I., Zuck E., Rotem C., Liberman U.A., Ravid A. Vitamin D is a prooxidant in breast cancer cells. Cancer Research. 61(4):2001;1439-1444.
16. Krill D., Stoner J., Konety B.R., Becich M.J., Getzenberg R.H. Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture. Urology. 54:1999;171-177.
17. 3 in growth regulation of cancer cell lines. Anticancer Research. 18(3A):1998;1769-1775.
18. 1 activity induced by doxorubicin in synchronized P 388 cells. Molecular Pharmacology. 49:1996;832-841.
19. Mahonen A., Jääskeläinen T., Mäenpää P.H. A novel vitamin D analog with two double bonds in its side chain. Biochemical Pharmacology. 51:1996;887-892.
20. 3 on improving prognosis of osteosarcoma patients. Oncology Reports. 8(2):2001;321-324.
21. 3. Cancer Letters. 151:2000;97-102.
22. 3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Research. 59:1999;862-867.
23. 1 arrest checkpoint in response to DNA damage. Molecular and Cellular Biology. 18(1):1998;378-387.
24. Siwińska, A., Kutner, A., Opolski, A., Radzikowski, Cz., April 2000. The Second Multidisciplinary Conference on Drug Research, Jelenia Góra-Cieplice. Biological Activity of New Analogs of Calcitriol. Book of Abstracts (W13).
25. Thielmann H.W., Popanda O. Doxorubicin and X rays increase the level of DNA topoisomerase II α in nuclei of normal and xeroderma pigmentosum fibroblasts. Journal of Cancer Research and Clinical Oncology. 124:1998;355-366.
26. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Research. 60:2000;2040-2048.
27. 3 and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells. Kidney Blood Pressure Research. 19(6):1996;325-331.